Antagonist Potency
Antagonist Potency is a pharmacological metric that quantifies the ability of an antagonist to inhibit the biological response of an agonist at a given receptor, distinguished from related potency measures by its specific focus on the inhibitory efficacy and concentration-dependent action of antagonistic substances.
2.9K
Publications
182.2K
Citations
13.5K
Authors
1.9K
Institutions
Publications per year
2017–2026
145
Parents
2.9K
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Murielle Rinaldi‐Carmona, Francis Barth, Michel Héaulme et al. · FEBS Letters · 1994 · 1.8K citations · Full text
Medicine, Neuroscience, Pharmacology +14
Quinoxalinediones: Potent Competitive Non-NMDA Glutamate Receptor Antagonists
Tage Honoré, S.N. Davies, Jørgen Drejer et al. · Science · 1988 · 1.2K citations
1–5 of 2.9K
13.5K
23
h-index
21
h-index
15
h-index
15
h-index
14
h-index
1–5 of 13.5K
1.9K
National Institutes of Health
Bethesda, United States
39 h-index
270 publications
15.9K citations
Merck & Co., Inc., Rahway, NJ, USA (United States)
Rahway, United States
38 h-index
322 publications
28.5K citations
New Frontier
Fallon, United States
29 h-index
199 publications
23.9K citations
Inserm
Paris, France
29 h-index
185 publications
9.3K citations

Centre National de la Recherche Scientifique
Paris, France
28 h-index
215 publications
10.2K citations
Sanofi (France)
Paris, France
28 h-index
221 publications
51.9K citations
National Institute of Diabetes and Digestive and Kidney Diseases
Bethesda, United States
26 h-index
187 publications
11.4K citations
University College London
London, United Kingdom
23 h-index
106 publications
8.4K citations
1–8 of 1.9K
BJP · 327 publications · 23.3K citations
80
h-index
302 publications · 19.6K citations
79
h-index
368 publications · 18.3K citations
70
h-index
102 publications · 8.3K citations
51
h-index
JBC · 86 publications · 8.2K citations
51
h-index
1–5